(Q34526180)

2 August 2017

title

Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance (English)

1 reference

2 August 2017

1 reference

Rodzynek JJ

1

1 reference

2 August 2017

Urbain D

2

1 reference

2 August 2017

Leautaud P

3

1 reference

2 August 2017

Wettendorff P

4

1 reference

2 August 2017

Delcourt A

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 October 1984

1 reference

2 August 2017

1 reference

2 August 2017

volume

25

1 reference

2 August 2017

issue

10

1 reference

2 August 2017

page(s)

1050-1056

1 reference

Metabolism of Fibrinogen in Cirrhosis of the Liver

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432549

Intravascular Coagulation in Liver Disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432549

Use of Normotest and Thrombotest, coagulation tests in hepatocellular disease.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432549

Observations of increased levels of blood coagulation factors and other plasma proteins in cholestatic liver disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432549

Methods for Determination of Plasmin, Antiplasmin and Plasminogen by Means of Substrate S-2251

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432549

Inhibition of plasmin by normal and antiplasmin-depleted human plasma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432549

The alpha2-plasmin inhibitor levels in liver diseases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432549

Improvement of some blood coagulation factors in cirrhotic patients treated with low doses of heparin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1432549

Antithrombin III versus prothrombin in liver cirrhosis

27 October 2018

1 reference

12 December 2020

Low antithrombin III in acute hepatic failure at term

1 reference

12 December 2020

Antithrombin III in rat hepatocytes

1 reference

12 December 2020

Synthesis of alpha 2-antiplasmin by rat liver cells

1 reference

12 December 2020

Fibrinolysis in cholestatic jaundice

1 reference

12 December 2020

Value of Normotest and antithrombin 3 in the assessment of liver function

1 reference

12 December 2020

Behaviour of antithrombin 3 in liver disease

1 reference

12 December 2020

Effect of hepatectomy on the posttraumatic fibrinolysis inhibition and the primary fibrinolysis inhibitor in the rat

1 reference

12 December 2020

[Rapid physiological coagulation method in determination of fibrinogen]

1 reference

12 December 2020

Thrombotest. A new method for controlling anticoagulant therapy

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.25.10.1050

1 reference

2 August 2017

1 reference

2 August 2017

1 reference